@prefix dc: . @prefix orcid: . @prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_head { this: np:hasAssertion dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion; np:hasProvenance dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_provenance; np:hasPublicationInfo dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_publicationInfo; a np:Nanopublication . dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion a np:Assertion . dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_provenance a np:Provenance . dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_publicationInfo a np:PublicationInfo . } dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion { miriam-gene:5604 a ncit:C16612 . lld:C0017638 a ncit:C7057 . dgn-gda:DGNdb9fbaef09b939fcb9f26ba4ff0827db sio:SIO_000628 miriam-gene:5604, lld:C0017638; a sio:SIO_001121 . } dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_provenance { dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_assertion dc:description "[We report here that: (a) in gliomas, [3H]TdR incorporation was enhanced by anti-Fas IgM monoclonal antibody CH-11 and conversely inhibited by anti-FasL monoclonal antibody NOK-2; (b) cross-linking of Fas with CH-11 drove both cell cycle progression and apoptosis as demonstrated by the induction of the S-G2 phase of DNA and RNA and fragmented nuclei; (c) phosphorylation of extracellular signal-regulated kinase (ERK), but not of c-Jun NH2-terminal kinase or p38, was induced by cross-linking of Fas; (d) a mitogen-activated protein kinase/ERK kinase 1 (MEK1) inhibitor PD98059 completely blocked CH-11-induced ERK phosphorylation as well as cell cycle progression without affecting induction of apoptosis; and (e) a broad-spectrum caspase inhibitor Z-Asp-CH2-DCB inhibited CH-11-induced ERK phosphorylation, cell cycle progression, and apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:10749152; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP808842.RAN2NTH8TTu379x5TE602EovTPOQCprwNYy1GzmnsRsoo130_publicationInfo { this: dc:created "2014-10-02T12:40:16+02:00"^^xsd:dateTime; dc:rights ; dc:rightsHolder dgn-void:IBIGroup; dc:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy orcid:0000-0001-5999-6269, orcid:0000-0002-7534-7661, orcid:0000-0002-9383-528X, orcid:0000-0003-0169-8159, orcid:0000-0003-1244-7654; pav:createdBy orcid:0000-0003-0169-8159; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }